Anti-human TNFSF11 monoclonal antibody, denosumab biosimilar (AMG162)

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1176-100ug

  • Size

    100 ug

  • Price

    $350

1
This monoclonal antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
target TNFSF11
alias CD254, hRANKL2, ODF, OPGL, OPTB2, RANKL, sOdf, TNLG6B, TRANCE
gene id Uniprote ID: O14788
host species Human
reactivity Human
iso type IgG2
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml, solubilize at RT for 30 minutes with occasional gentle tapping. It is recommended that 0.1% HSA be added as a carrier protein for long-term storage.
applications Flow Cytometry
dilution Flow Cyt 1:100
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.
note Other commonly used names in publications refering to this antibody: AMG162

Images

HEK293 cell line transfected with irrelevant protein (red histogram) and human TNFSF11 protein (blue histogram) were surface stained with anti-TNFSF11 (denosumab biosimilar)mAb 1ug/ml followed by Alexa 488-conjugated Goat anti-Human IgG secondary antibody.


PRODUCT

  • SKU

    DMS1176-100ug

  • Size

    100 ug

  • Price

    $350

1